BRUSSELS (Reuters) - The European Union expects Johnson & Johnson to deliver the first doses of its COVID-19 vaccine in April after approval from the EU drug regulator, a senior EU official told Reuters on Wednesday.
The official, who is involved in negotiations with vaccine makers and spoke on condition of anonymity, said the J&J shot, which is administered in a single dose, could be available from April 1.
Earlier on Wednesday an EU lawmaker said the EU health commissioner had told an internal meeting in the Parliament that Johnson & Johnson was likely to submit an application to the EU drug regulator in February.
Reporting by Francesco Guarascio; Editing by Chris Reese
Our Standards: The Thomson Reuters Trust Principles.